Mylan Pharmaceuticals Inc. et al. v. Bayer Pharma AG et al. > Summary
Court Case Number IPR2022-00517
Filing Date Feb 2, 2022
Institution Decision Date Aug 9, 2022
Decision Date Jul 28, 2023
Court Patent Trial and Appeal Board
Status Final Written Decision - Appeale
Appeal2023-2434
Administrative JudgesTina E. Hulse, Ryan H. Flax
Judge Writing the Final DecisionTina E. Hulse
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8
Claims Instituted: 1, 2, 3, 4, 5, 6, 7, 8
Claims Invalidated: 1, 2, 3, 4, 5, 6, 7, 8
Petitioner
Patent Owner
Petitioner Attorneys
11Viatris Inc.
Attorney Name: Grace A. Winschel
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Wendy L. Devine
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Ellie F. Steiner
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Chandrika Vira
Sterne, Kessler, Goldstein & Fox
Viatris Inc.
Attorney Name: Neal Seth
Wiley Rein LLP
Viatris Inc.
Attorney Name: Susannah M. L. Gagnon
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Teresa Summers
Wiley Rein LLP
West, Randall M.
Attorney Name: Randall M. Zusman
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Trey Powers III
Sterne, Kessler, Goldstein & Fox
MYLAN PHARMACEUTICALS ULC(Viatris)
Attorney Name: Bindu A. G. Palapura
Potter Anderson & Corroon
Patent Owner Attorneys
6Bayer Pharma AG
Attorney Name: Dov P. Grossman
Williams & Connolly
Bayer Pharma AG
Attorney Name: Julie L. Tavares
Williams & Connolly
Bayer Pharma AG
Attorney Name: Alexander S. Zolan
Williams & Connolly
Bayer Pharma AG
Attorney Name: Kathryn S. Kayali
Williams & Connolly
Bayer Pharma AG
Attorney Name: Jeffrey Weitz
McMaster University
Bayer Pharma AG
Attorney Name: Bruce R. Genderson
Williams & Connolly
Related Patents
Doc No | Title | Issue date |
---|---|---|
10828310 | Reducing the risk of cardiovascular events | Nov 10, 2020 |